These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 32345264)
1. Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel. Yi X; Zhou Q; Zhang Y; Zhou J; Lin J BMC Neurol; 2020 Apr; 20(1):159. PubMed ID: 32345264 [TBL] [Abstract][Full Text] [Related]
2. Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke. Yi X; Wang Y; Lin J; Cheng W; Zhou Q; Wang C Clin Appl Thromb Hemost; 2017 Oct; 23(7):761-768. PubMed ID: 27233747 [TBL] [Abstract][Full Text] [Related]
3. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161 [TBL] [Abstract][Full Text] [Related]
4. Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke. Yi X; Zhou Q; Wang C; Lin J; Liu P; Fu C Eur J Clin Pharmacol; 2017 Apr; 73(4):437-443. PubMed ID: 28091702 [TBL] [Abstract][Full Text] [Related]
5. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Yi X; Zhou Q; Wang C; Lin J; Chai Z J Neurol; 2018 Oct; 265(10):2396-2403. PubMed ID: 30128710 [TBL] [Abstract][Full Text] [Related]
6. Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. Yi X; Lin J; Wang Y; Zhou Q; Wang C; Cheng W; Chi L J Atheroscler Thromb; 2016 Oct; 23(10):1188-1200. PubMed ID: 26961113 [TBL] [Abstract][Full Text] [Related]
7. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731 [TBL] [Abstract][Full Text] [Related]
8. Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients. Yi X; Wang C; Zhou Q; Lin J BMC Neurol; 2017 Jan; 17(1):4. PubMed ID: 28068952 [TBL] [Abstract][Full Text] [Related]
9. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response. Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117 [TBL] [Abstract][Full Text] [Related]
10. Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke. Liu R; Zhou ZY; Chen YB; Li JL; Yu WB; Chen XM; Zhao M; Zhao YQ; Cai YF; Jin J; Huang M Acta Pharmacol Sin; 2016 Jul; 37(7):882-8. PubMed ID: 27133299 [TBL] [Abstract][Full Text] [Related]
11. CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Jia DM; Chen ZB; Zhang MJ; Yang WJ; Jin JL; Xia YQ; Zhang CL; Shao Y; Chen C; Xu Y Stroke; 2013 Jun; 44(6):1717-9. PubMed ID: 23640828 [TBL] [Abstract][Full Text] [Related]
12. Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study. Fu H; Hu P; Ma C; Peng F; He Z Medicine (Baltimore); 2020 Apr; 99(15):e19472. PubMed ID: 32282698 [TBL] [Abstract][Full Text] [Related]
13. The TXA2R rs1131882, P2Y1 rs1371097 and GPIIIa rs2317676 three-loci interactions may increase the risk of carotid stenosis in patients with ischemic stroke. Yi X; Lin J; Zhou Q; Huang R; Chai Z BMC Neurol; 2019 Mar; 19(1):44. PubMed ID: 30914039 [TBL] [Abstract][Full Text] [Related]
14. Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2. Yi X; Han Z; Zhou Q; Cheng W; Lin J; Wang C Clin Appl Thromb Hemost; 2018 Jan; 24(1):55-62. PubMed ID: 27637911 [TBL] [Abstract][Full Text] [Related]
15. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy. Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y; Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080 [TBL] [Abstract][Full Text] [Related]
16. Genotype Frequencies of CYP2C19, P2Y12 and GPIIIa Polymorphisms in Coronary Heart Disease Patients of Han Ethnicity, and Their Impact on Clopidogrel Responsiveness. Ou W; He Y; Li A; Liu B; Jin L Int Heart J; 2016 Sep; 57(5):586-92. PubMed ID: 27488401 [TBL] [Abstract][Full Text] [Related]
17. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921 [TBL] [Abstract][Full Text] [Related]
18. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y; JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211 [TBL] [Abstract][Full Text] [Related]
19. Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis. Yan Y; Hao R; Zhao X; Xia X; Wang L; Li X J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106798. PubMed ID: 36215918 [TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of response to clopidogrel and cardiovascular events. Simon T; Verstuyft C; Mary-Krause M; Quteineh L; Drouet E; Méneveau N; Steg PG; Ferrières J; Danchin N; Becquemont L; N Engl J Med; 2009 Jan; 360(4):363-75. PubMed ID: 19106083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]